Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
CA$0.16 - CA$0.33
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$16.38M |
EV | CA$14.82M |
Shares Outstanding | 90.11M |
Beta | 3.35 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2023E | - |
P/Revenue 2023E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2023E | - |
Net Profit Margin 2023E | - |
ROE 2023E | - |
ROCE 2022 | -46.06% |
DPS 2023E | - |
Payout Ratio 2023E | - |
Div. Yield 2023E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
PharmaTher Holdings Ltd.
PHRM
Sector
Healthcare
Industry
Biotechnology
CEO
Chianelli, Fabio
Employees
Website
www.pharmather.comIPO Date
2021-04-13
Headquarters
82 Richmond Street East, Toronto, Ontario, M5C 1P1, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved